<!DOCTYPE html>
<html lang="en-us">
<head>
        
<meta name="google-site-verification" content="P6tzsvCY6tAhptB_3vuWyq4ycjyYl__ZAvgeI_phS-M" />

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Source Themes Academic 2.4.0">
  <meta name="generator" content="Hugo 0.55.6" />
  <meta name="author" content="Dan Han">

  
  
  
  
    
  
  <meta name="description" content="The 340B Drug Pricing Program entitles about 45% of U.S. hospitals to steep discounts on most outpatient drugs. Due to a predominant mix of public payers that reimburse at costs, the financial implications of 340B for Critical Access Hospitals (CAH) differ widely from those for their non-CAH peers but have received little attention in the literature or policy world. In this work, I present the stark contrast of 340B&rsquo;s financial impact between CAHs and non-CAH hospitals.">

  
  <link rel="alternate" hreflang="en-us" href="https://dhan1024.github.io/project/working-340b-hospital-financial-outcome/">

  


  

  
  
  
  <meta name="theme-color" content="#21366E">
  

  
  
  
  
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.3.7/css/bootstrap.min.css" integrity="sha512-6MXa8B6uaO18Hid6blRMetEIoPqHf7Ux1tnyIQdpt9qI5OACx7C+O3IVTr98vwGnlcg0LOLa02i9Y1HpVhlfiw==" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css" integrity="sha512-SfTiTlX6kk+qitfevl/7LibUOeJWlt9rbyDn92a1DqWOw9vWG2MFoays0sgObmWazO5BQPiFucnnEAjpAB+/Sw==" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.css" integrity="sha256-ygkqlh3CYSUri3LhQxzdcm0n1EQvH2Y+U5S2idbLtxs=" crossorigin="anonymous">

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/styles/github.min.css" crossorigin="anonymous">
        
      
    

    

    

  

  
  
  <link rel="stylesheet" href="//fonts.googleapis.com/css?family=Lato:400,700%7cMerriweather%7cRoboto&#43;Mono">
  

  <link rel="stylesheet" href="/styles.css">
  
  <link rel="stylesheet" href="/css/custom.css">
  

  
  
  

  
  <link rel="alternate" href="https://dhan1024.github.io/index.xml" type="application/rss+xml" title="Dan Han">
  <link rel="feed" href="https://dhan1024.github.io/index.xml" type="application/rss+xml" title="Dan Han">
  

  <link rel="manifest" href="/site.webmanifest">
  <link rel="icon" type="image/png" href="/img/icon.png">
  <link rel="apple-touch-icon" type="image/png" href="/img/icon-192.png">

  <link rel="canonical" href="https://dhan1024.github.io/project/working-340b-hospital-financial-outcome/">

  <meta property="twitter:card" content="summary_large_image">
  
  <meta property="og:site_name" content="Dan Han">
  <meta property="og:url" content="https://dhan1024.github.io/project/working-340b-hospital-financial-outcome/">
  <meta property="og:title" content="Hospital Financial Outcomes under the 340B Drug Pricing Program – A Tale of Two Payment Systems | Dan Han">
  <meta property="og:description" content="The 340B Drug Pricing Program entitles about 45% of U.S. hospitals to steep discounts on most outpatient drugs. Due to a predominant mix of public payers that reimburse at costs, the financial implications of 340B for Critical Access Hospitals (CAH) differ widely from those for their non-CAH peers but have received little attention in the literature or policy world. In this work, I present the stark contrast of 340B&rsquo;s financial impact between CAHs and non-CAH hospitals.">
  <meta property="og:locale" content="en-us">
  
  <meta property="article:published_time" content="2018-08-18T00:00:00&#43;00:00">
  
  <meta property="article:modified_time" content="2019-07-06T14:42:21-04:00">
  

  

  

  <title>Hospital Financial Outcomes under the 340B Drug Pricing Program – A Tale of Two Payment Systems | Dan Han</title>

</head>
<body id="top" data-spy="scroll" data-target="#toc" data-offset="71" >

<nav class="navbar navbar-default navbar-fixed-top" id="navbar-main">
  <div class="container">

    
    <div class="navbar-header">
      
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse"
              data-target=".navbar-collapse" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      
      <a class="navbar-brand" href="/">Dan Han</a>
    </div>

    
    <div class="collapse navbar-collapse">

      
      
      <ul class="nav navbar-nav navbar-right">
        

        
        
        
        
        
          
        

        <li class="nav-item">
          <a href="/#about">
            
            <span>Home</span>
            
          </a>
        </li>

        
        

        
        
        
        
        
          
        

        <li class="nav-item">
          <a href="/#contact">
            
            <span>Contact</span>
            
          </a>
        </li>

        
        

        
        
        
        
        
          
        

        <li class="nav-item">
          <a href="/#research">
            
            <span>Research</span>
            
          </a>
        </li>

        
        

        
        
        
        
        
          
        

        <li class="nav-item">
          <a href="/#publications">
            
            <span>Publications</span>
            
          </a>
        </li>

        
        

        
        
        
        
        

        <li class="nav-item">
          <a href="/#cv">
            
            <span>CV</span>
            
          </a>
        </li>

        
        
      

      
      </ul>

    </div>
  </div>
</nav>


<article class="article article-project" itemscope itemtype="http://schema.org/Article">

  


  <div class="article-container">

    <div class="pub-title">
      <h1 itemprop="name">Hospital Financial Outcomes under the 340B Drug Pricing Program – A Tale of Two Payment Systems</h1>
      <span class="pub-authors" itemprop="author">&nbsp;</span>
      <span class="pull-right">
        

      </span>
    </div>

    

    <div class="article-style" itemprop="articleBody">
      <p>The 340B Drug Pricing Program entitles about 45% of U.S. hospitals to steep discounts on most outpatient drugs.  Due to a predominant mix of public payers that reimburse at costs, the financial implications of 340B for Critical Access Hospitals (CAH) differ widely from those for their non-CAH peers but have received little attention in the literature or policy world.  In this work, I present the stark contrast of 340B&rsquo;s financial impact between CAHs and non-CAH hospitals. Using event studies that exploit the timing of hospitals joining 340B and hospital-level data, I document an increase in profit margin and supply of outpatient drugs at non-CAH hospitals, but little change to either margin or supply at CAHs under 340B, which corroborates findings from previous research based on patient-level data. Accompanying these changes in supply and margin, or the lack thereof, profits go up for non-CAH hospitals but decrease for CAHs. To explain why most CAHs participate in 340B despite the foregone revenue, I show that rising drug costs along with declining cash appear to motivate a high take-up rate. I also find that 340B benefits CAHs primarily by freeing up cash for meeting other operating expenses - a result robust to excluding hospitals that discontinued unprofitable services during the study period. While the negative effect on profits for CAHs spill over to a reduction in the offering of unprofitable services, the extra surplus obtained by non-CAH hospitals under 340B does not translate into an increase in the offering of unprofitable services. As a complementary approach, I estimate similar effects for non-CAH hospitals using a fuzzy regression discontinuity design that exploits an eligibility threshold specific to these hospitals, which bolsters my main results. These findings provide direct evidence that some non-CAH hospitals are capitalizing on 340B, and raise concerns over the program’s unanticipated effect on CAHs’ financial stability.</p>

    </div>

    


    
    
    

    
      
      
      
      

      
      
      
      
    

  </div>
</article>



<footer class="site-footer">
  <div class="container">

    

    <p class="powered-by">

      &copy; 2018 &middot; 

      Powered by the
      <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
      <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

      <span class="pull-right" aria-hidden="true">
        <a href="#" id="back_to_top">
          <span class="button_icon">
            <i class="fa fa-chevron-up fa-2x"></i>
          </span>
        </a>
      </span>

    </p>
  </div>
</footer>


<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <button type="button" class="close btn-large" data-dismiss="modal">&times;</button>
        <h4 class="modal-title">Cite</h4>
      </div>
      <div>
        <pre><code class="modal-body tex"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-primary btn-outline js-copy-cite" href="#" target="_blank">
          <i class="fa fa-copy"></i> Copy
        </a>
        <a class="btn btn-primary btn-outline js-download-cite" href="#" target="_blank">
          <i class="fa fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

    

    
    

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.2.1/jquery.min.js" integrity="sha512-3P8rXCuGJdNZOnUx/03c1jOTnMn3rP63nBip5gOP2qmUh5YAdVAvFZ1E+QLZZbC1rtMrQb+mah3AfYW11RUrWA==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.3/imagesloaded.pkgd.min.js" integrity="sha512-umsR78NN0D23AzgoZ11K7raBD+R6hqKojyBZs1w8WvYlsI+QuKRGBx3LFCwhatzBunCjDuJpDHwxD13sLMbpRA==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha512-iztkobsvnjKfAtTNdHkGVjAYTrrtlC7mGp/54c40wowO7LhURYl3gVzzcEqGl/qKXQltJ2HwMrdLcNUdo+N/RQ==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.4/isotope.pkgd.min.js" integrity="sha512-VDBOIlDbuC4VWxGJNmuFRQ0Li0SKkDpmGyuhAG5LTDLd/dJ/S0WMVxriR2Y+CyPL5gzjpN4f/6iqWVBJlht0tQ==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.js" integrity="sha256-X5PoE3KU5l+JcX+w09p/wHl9AzK333C4hJ2I9S5mD4M=" crossorigin="anonymous"></script>

      
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/highlight.min.js" integrity="sha256-/BfiIkHlHoVihZdc6TFuj7MmJ0TWcWsMXkeDFwhi0zw=" crossorigin="anonymous"></script>
        
      

      
      
    

    <script src="/js/hugo-academic.js"></script>
    

    
    

    
    
    

    
    
    <script>hljs.initHighlightingOnLoad();</script>
    

    
    
    <script>
      const search_index_filename = "/search.json";
      const i18n = {
        'placeholder': "Search...",
        'no_results': "No results found"
      };
      const content_type = {
        'post': "Posts",
        'project': "Projects",
        'publication' : "Publications",
        'talk' : "Talks"
        };
    </script>
    

    
    

    
    

  </body>
</html>

